piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation
Cellular Signalling
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation. // Cellular Signalling. – URL: https://www.sciencedirect.com/science/article/pii/S0898656826006388?dgcid=rss_sd_all
piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation. Cellular Signalling. https://www.sciencedirect.com/science/article/pii/S0898656826006388?dgcid=rss_sd_all
“piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation.” Cellular Signalling.
@article{article40111,
title = {piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation},
journal = {Cellular Signalling},
url = {https://www.sciencedirect.com/science/article/pii/S0898656826006388?dgcid=rss_sd_all}
}